1. COVID-19 mortality among migrants living in Italy.
- Author
-
Canevelli M, Palmieri L, Raparelli V, Punzo O, Donfrancesco C, Lo Noce C, Vanacore N, Brusaferro S, and Onder G
- Subjects
- Adult, Age Distribution, Aged, Aged, 80 and over, Albania ethnology, COVID-19, Cardiovascular Diseases epidemiology, Cause of Death, Comorbidity, Diabetes Mellitus, Type 2 epidemiology, Female, France ethnology, Healthy Worker Effect, Hospital Records, Humans, Italy epidemiology, Male, Middle Aged, Mortality ethnology, Neoplasms epidemiology, Obesity epidemiology, Pulmonary Disease, Chronic Obstructive epidemiology, Renal Insufficiency, Chronic epidemiology, SARS-CoV-2, Betacoronavirus, Coronavirus Infections mortality, Pandemics, Pneumonia, Viral mortality, Transients and Migrants statistics & numerical data
- Abstract
We aimed to compare COVID-19-specific and all-cause mortality rates among natives and migrants in Italy and to investigate the clinical characteristics of individuals dying with COVID-19 by native/migrant status. The mortality rates and detailed clinical characteristics of natives and migrants dying with COVID-19 were explored by considering the medical charts of a representative sample of patients deceased in Italian hospitals (n = 2,687) between February 21st and April 29th, 2020. The migrant or native status was assigned based on the individual's country of birth. The expected all-cause mortality among natives and migrants living in Italy was derived by the last available (2018) dataset provided by the Italian National Institute of Statistics. Overall, 68 individuals with a migration background were identified. The proportions of natives and migrants among the COVID-19-related deaths (97.5% and 2.5%, respectively) were similar to the relative all-cause mortality rates estimated in Italy in 2018 (97.4% and 2.6%, respectively). The clinical phenotype of migrants dying with COVID-19 was similar to that of natives except for the younger age at death. International migrants living in Italy do not have a mortality advantage for COVID-19 and are exposed to the risk of poor outcomes as their native counterparts.
- Published
- 2020
- Full Text
- View/download PDF